The Expression of TP53TG1, LINC00342, MALAT1, H19, and MEG3 Long Noncoding RNAs in Type 2 diabetes mellitus

Fuchsberger C., Flannick J., Teslovich T.M., Mahajan A., Agarwala V., Gaulton K.J., Ma C., Fontanillas P., Moutsianas L., McCarthy D.J., Rivas M.A., Perry J.R.B., Sim X., Blackwell T.W., Robertson N.R., Rayner N.W., Cingolani P., Locke A.E., Tajes J.F., Highland H.M., Dupuis J., Chines P.S., Lindgren C.M., Hartl C., Jackson A.U., Chen H., Huyghe J.R., van de Bunt M., Pearson R.D., Kumar A., Müller-Nurasyid M., Grarup N., Stringham H.M., Gamazon E.R., Lee J., Chen Y., Scott R.A., Below J.E., Chen P., Huang J., Go M.J., Stitzel M.L., Pasko D., Parker S.C.J., Varga T.V., Green T., Beer N.L., Day-Williams A.G., Ferreira T., Fingerlin T., Horikoshi M., Hu C., Huh I., Ikram M.K., Kim B.J., Kim Y., Kim Y.J., Kwon M.S., Lee J., Lee S., Lin K.H., Maxwell T.J., Nagai Y., Wang X., Welch R.P., Yoon J., Zhang W., Barzilai N., Voight B.F., Han B.G., Jenkinson C.P., Kuulasmaa T., Kuusisto J., Manning A., Ng M.C.Y., Palmer N.D., Balkau B., Stančáková A., Abboud H.E., Boeing H., Giedraitis V., Prabhakaran D., Gottesman O., Scott J., Carey J., Kwan P., Grant G., Smith J.D., Neale B.M., Purcell S., Butterworth A.S., Howson J.M.M., Lee H.M., Lu Y., Kwak S.H., Zhao W., Danesh J., Lam V.K.L., Park K.S., Saleheen D., So W.Y., Tam C.H.T., Afzal U., Aguilar D., Arya R., Aung T., Chan E., Navarro C., Cheng C.Y., Palli D., Correa A., Curran J.E., Rybin D., Farook V.S., Fowler S.P., Freedman B.I., Griswold M., Hale D.E., Hicks P.J., Khor C.C., Kumar S., Lehne B., Thuillier D., Lim W.Y., Liu J., van der Schouw Y.T., Loh M., Musani S.K., Puppala S., Scott W.R., Yengo L., Tan S.T., Taylor H.A. Jr., Thameem F., Wilson G.Sr., Wong T.Y., Njølstad P.R., Levy J.C., Mangino M., Bonnycastle L.L., Schwarzmayr T., Fadista J., Surdulescu G.L., Herder C., Groves C.J., Wieland T., Bork-Jensen J., Brandslund I., Christensen C., Koistinen H.A., Doney A.S.F., Kinnunen L., Esko T., Farmer A.J., Hakaste L., Hodgkiss D., Kravic J., Lyssenko V., Hollensted M., Jørgensen M.E., Jørgensen T., Ladenvall C., Justesen J.M., Käräjämäki A., Kriebel J., Rathmann W., Lannfelt L., Lauritzen T., Narisu N., Linneberg A., Melander O., Milani L., Neville M., Orho-Melander M., Qi L., Qi Q., Roden M., Rolandsson O., Swift A., Rosengren A.H., Stirrups K., Wood A.R., Mihailov E., Blancher C., Carneiro M.O., Maguire J., Poplin R., Shakir K., Fennell T., DePristo M., de Angelis M.H., Deloukas P., Gjesing A.P., Jun G., Nilsson P., Murphy J., Onofrio R., Thorand B., Hansen T., Meisinger C., Hu F.B., Isomaa B., Karpe F., Liang L., Peters A., Huth C., O’Rahilly S.P., Palmer C.N.A., Pedersen O., Rauramaa R., Tuomilehto J., Salomaa V., Watanabe R.M., Syvänen A.C., Bergman R.N., Bharadwaj D., Bottinger E.P., Cho Y.S., Chandak G.R., Chan J.C.N., Chia K.S., Daly M.J., Ebrahim S.B., Langenberg C., Elliott P., Jablonski K.A., Lehman D.M., Jia W., Ma R.C.W., Pollin T.I., Sandhu M., Tandon N., Froguel P., Barroso I., Teo Y.Y., Zeggini E., Loos R.J.F., Small K.S., Ried J.S., DeFronzo R.A., Grallert H., Glaser B., Metspalu A., Wareham N.J., Walker M., Banks E., Gieger C., Ingelsson E., Im H.K., Illig T., Franks P.W., Buck G., Trakalo J., Buck D., Prokopenko I., Mägi R., Lind L., Farjoun Y., Owen K.R., Gloyn A.L., Strauch K., Tuomi T., Kooner J.S., Lee J.Y., Park T., Donnelly P., Morris A.D., Hattersley A.T., Bowden D.W., Collins F.S., Atzmon G., Chambers J.C., Spector T.D., Laakso M., Strom T.M., Bell G.I., Blangero J., Duggirala R., Tai E.S., McVean G., Hanis C.L., Wilson J.G., Seielstad M., Frayling T.M., Meigs J.B., Cox N.J., Sladek R., Lander E.S., Gabriel S., Burtt N.P., Mohlke K.L., Meitinger T., Groop L., Abecasis G., Florez J.C., Scott L.J., Morris A.P., Kang H.M., Boehnke M., Altshuler D., McCarthy M.I. 2016. The genetic architecture of type 2 diabetes. Nature. 536 (7614), 41‒47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li R., Zhu H., Luo Y. 2016. Understanding the functions of long non-coding RNAs through their higher-order structures. Int. J. Mol. Sci. 17 (5), 702.

Article  PubMed  PubMed Central  Google Scholar 

Alfaifi M., Ali Beg M.M., Alshahrani M.Y., Ahmad I., Alkhathami A.G., Joshi P.C., Alshehri O.M., Alamri A.M., Verma A.K. 2021. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus. BMJ Open Diabetes Res. Care. 9 (1), e001821.

Article  PubMed  PubMed Central  Google Scholar 

López-Noriega L., Rutter G.A. 2021. Long non-coding RNAs as key modulators of pancreatic β-cell mass and function. Front. Endocrinol. (Lausanne). 11, 610213.

Article  PubMed  Google Scholar 

Xiong L., Gong Y., Wu L., Li J., He W., Zhu X., Xiao H. 2020. LncRNA-MALAT1 is involved in lipotoxicity-induced ß-cell dysfunction and the therapeutic effect of exendin-4 via Ptbp1. Endocrinology. 161 (7), bqaa065. https://doi.org/10.1210/endocr/bqaa065

Noh J.H., Kim K.M., McClusky W.G., Abdelmohsen K., Gorospe M. 2018. Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip. Rev. RNA. 9 (3), e1471. https://doi.org/10.1002/wrna.147

Article  PubMed  PubMed Central  Google Scholar 

Novikova LB., Gareev IF., Raskurazhev A.A., Beylerli O.A., Minibaeva G.M. 2020. The role of long noncoding RNA in ischemic stroke. Ann. Klin. Eksp. Nevrol. 14 (1), 70–77.

Google Scholar 

Sohrabifar N., Ghaderian S., Alipour P.S., Ghaedi H., Jafari H. 2022. Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus. Arch. Physiol. Biochem. 128 (5), 1308‒1315.

Article  CAS  PubMed  Google Scholar 

Lu Q., Guo P., Liu A., Ares I., Martínez-Larrañaga M.R., Wang X., Anadón A., Martínez M.A. 2021. The role of long noncoding RNA in lipid, cholesterol, and glucose metabolism and treatment of obesity syndrome. Med. Res. Rev. 41 (3), 1751‒1774.

Article  CAS  PubMed  Google Scholar 

Chen X., Gao Y., Li D., Cao Y., Hao B. 2017. L-ncRNA-TP53TG1 participated in the stress response under glucose deprivation in glioma. J. Cell Biochem. 118 (12), 4897‒4904.

Article  CAS  PubMed  Google Scholar 

Li T., Tong H., Zhu J., Qin Z., Yin S., Sun Y., Liu X., He W. 2022. Identification of a three-glycolysis-related lncRNA signature correlated with prognosis and metastasis in clear cell renal cell carcinoma. Front. Med. (Lausanne). 8, 777507.

Article  Google Scholar 

Russo S., Kwiatkowski M., Govorukhina N., Bischoff R., Melgert B.N. 2021. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: The importance of metabolites. Front. Immunol. 12, 74615.

Article  Google Scholar 

Li C., Su F., Liang Z., Zhang L., Liu F., Fan W., Li Z. 2022. Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of l-ncRNA expression. Mol. Immunol. 144, 16‒25.

Article  CAS  PubMed  Google Scholar 

Yang Z., Yu G.L., Zhu X., Peng T.H., Lv Y.C. 2022. Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders. Genes Dis. 9 (1), 51‒61.

Article  PubMed  Google Scholar 

Braga E.A., Fridman M.V., Moscovtsev A.A., Filippova E.A., Dmitriev A.A., Kushlinskii N.E. 2020. Ln-cRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int. J. Mol. Sci. 21 (22), 8855.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cremer S., Michalik K.M., Fischer A., Pfisterer L., Jaé N., Winter C., Boon R.A., Muhly-Reinholz M., John D., Uchida S., Weber C., Poller W., Günther S., Braun T., Li D.Y., Maegdefessel L., Perisic Matic L., Hedin U., Soehnlein O., Zeiher A., Dimmeler S. 2019. Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation. 139 (10), 1320‒1334.

Article  CAS  PubMed  Google Scholar 

Che F., Han Y., Fu J., Wang N., Jia Y., Wang K., Ge J. 2021. LncRNA MALAT1 induced by hyperglycemia promotes microvascular endothelial cell apoptosis through activation of the miR-7641/TPR axis to exacerbate neurologic damage caused by cerebral small vessel disease. Ann. Transl. Med. 9 (24), 1762.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milluzzo A., Maugeri A., Barchitta M., Sciacca L., Agodi A. 2021. Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review. Int. J. Mol. Sci. 22 (19), 10502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S., Duan J., Liao J., Wang Y., Xiao X., Li L., Liu Y., Gu H., Yang P., Fu D., Du J., Li X., Shao M. 2022. LncRNA H19 inhibits ER stress induced apoptosis and improves diabetic cardiomyopathy by regulating PI3K/AKT/mTOR axis. Aging (Albany NY). 14 (16), 6809‒6828.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar A., Datta M. 2022. H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes. Mol. Med. 28 (1), 81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang W., Lyu Y., Xiang R., Yang J. 2022. Long noncoding RNAs in the pathogenesis of insulin resistance. Int. J. Mol. Sci. 23 (24), 16054.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu X., Wu Y.B., Zhou J., Kang D.M. 2016. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression. Biochem. Biophys. Res. Commun. 469 (2), 319‒325.

Article  CAS  PubMed  Google Scholar 

Unnikrishnan R., Pradeepa R., Joshi S.R., Mohan V. 2017. Type 2 diabetes: Demystifying the global epidemic. Diabetes. 66 (6), 1432‒1442.

Article  CAS  PubMed  Google Scholar 

Dedov I.I., Shestakova M.V., Mayorov A.Y., Mokryshiva N.G, Vikulova O.K., Galstain G.R., Shestako-va E.A. 2022. Standards of specialized diabetes care. Diabetes mellitus. 24 (1S), 1‒148.

Livak K.J., Schmittgen T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 25 (4), 402‒408.

Article  CAS  PubMed  Google Scholar 

Alrefai A.A., Khader H.F., Elbasuony H.A., Elzorkany K.M., Saleh A.A. 2023. Evaluation of the expression levels of lncRNAs H19 and MEG3 in patients with type 2 diabetes mellitus. Mol. Biol. Rep. 50 (7), 6075‒6085. https://doi.org/10.1007/s11033-023-08569-0

Article  CAS  PubMed  Google Scholar 

Taheri M., Eghtedarian R., Ghafouri-Fard S., Omrani M.D. 2023. Non-coding RNAs and type 2 diabetes mellitus. Arch. Physiol. Biochem. 129 (2), 526‒535.

Article  CAS  PubMed  Google Scholar 

Huang Y., Zhou Z., Zhang J., Hao Z., He Y., Wu Z., Song Y., Yuan K., Zheng S., Zhao Q., Li T., Wang B. 2021. lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell. J. Cell Mol. Med. 25 (15), 7135‒7145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang H., Zhao L., Li M., Li T., Hao Y. 2019. Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer. J. Cell. Biochem. 120 (4), 5055‒5061.

Article  CAS  PubMed  Google Scholar 

Liu C., Xu Y., Wu X., Zou Q. 2019. Clinical significance of linc00342 expression in the peripheral blood lymphocytes of patients with chronic kidney disease. Int. J. Nephrol. Renovasc. Dis. 12, 251‒256.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif